Regenerative medicine is the branch of medicine that develops methods to regrow, repair, or replace damaged or diseased cells, organs, or tissues. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications.
Several important factors are responsible to boost the growth of the global Regenerative Medicine market, these are the rise of stem cell technology, untapped potential of nanotechnology, growing prevalence of chronic diseases & trauma emergencies, advancement in monitoring devices, and surgical technologies. Moreover, other crucial factors such as the rising incidence of degenerative diseases, scarcity of organs for transplantation, increasing focus on stem cells, and growth in R&D activities in developing countries are significantly contributing to the growth of the global Regenerative Medicine market.
On the downside, stringent government regulations, operational inefficiency, and the high cost of treatment through regenerative medicine are projected to hamper the growth of the market.
Covid-19 Impact on Regenerative Medicine Market
In addition, the current Regenerative Medicine Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Regenerative Medicine Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Regenerative Medicine Market Segment Overview
Based on products, the Tissue-engineered Products segment has the maximum share in the Regenerative Medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors escalating the growth of this segment. By Application, the Musculoskeletal segment accounted for the largest share of the market in 2019. This can be mainly attributed to the increasing prevalence of orthopedic diseases, rising old age population, an increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.
Regenerative Medicine Market, By Product
- Tissue-engineered Products
- Cell Therapies
- Autologous Therapies
- Allogenic Therapies
- Gene Therapies
- Progenitor & Stem Cell Therapies
· Cardiovascular
· Oncology
· Dermatology
· Musculoskeletal
· Wound Healing
· Ophthalmology
· Neurology
· Others
Regenerative Medicine Market Regional Overview
Based on the region, North America dominates the global Regenerative Medicine market. The U.S. contributes a major share in the market as it carried out a wide range of research and development activities. Also, other reasons such as the growing old age population and the high medical spends of the overall population are expected to fuel the growth of the market in this region. Likewise, Asia Pacific is expected to be the prominent region for the Regenerative Medicine market in the coming years. Various factors such as the growing development of healthcare infrastructure, increasing awareness about regenerative medicines, and the good ability of people to spend on better treatments are majorly contributing to the growth of the market in this region.
Regenerative Medicine Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Regenerative Medicine Market, Key Players
· Stryker Corporation
· Zimmer Biomet Holdings, Inc.
· Medtronic Plc.
· Athersys, Inc.
· U.S. Stem Cell, Inc. (Bioheart, Inc.)
· Organogenesis, Inc. (Advanced Biohealing)
· Integra Lifesciences Holdings Corporation
· Acelity Holdings, Inc.
· Isto Biologics (Isto Biologics Medical Systems, Inc.)
· CryoLife, Inc.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Regenerative Medicine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Tissue-engineered Products
- 5.2.2. Cell Therapies
- 5.2.2.1. Autologous Therapies
- 5.2.2.2. Allogenic Therapies
- 5.2.3. Gene Therapies
- 5.2.4. Progenitor & Stem Cell Therapies
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Cardiovascular
- 5.3.2. Oncology
- 5.3.3. Dermatology
- 5.3.4. Musculoskeletal
- 5.3.5. Wound Healing
- 5.3.6. Ophthalmology
- 5.3.7. Neurology
- 5.3.8. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East and Africa
6. North America Regenerative Medicine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Tissue-engineered Products
- 6.2.2. Cell Therapies
- 6.2.2.1. Autologous Therapies
- 6.2.2.2. Allogenic Therapies
- 6.2.3. Gene Therapies
- 6.2.4. Progenitor & Stem Cell Therapies
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Cardiovascular
- 6.3.2. Oncology
- 6.3.3. Dermatology
- 6.3.4. Musculoskeletal
- 6.3.5. Wound Healing
- 6.3.6. Ophthalmology
- 6.3.7. Neurology
- 6.3.8. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Regenerative Medicine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Tissue-engineered Products
- 7.2.2. Cell Therapies
- 7.2.2.1. Autologous Therapies
- 7.2.2.2. Allogenic Therapies
- 7.2.3. Gene Therapies
- 7.2.4. Progenitor & Stem Cell Therapies
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Cardiovascular
- 7.3.2. Oncology
- 7.3.3. Dermatology
- 7.3.4. Musculoskeletal
- 7.3.5. Wound Healing
- 7.3.6. Ophthalmology
- 7.3.7. Neurology
- 7.3.8. Others
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Regenerative Medicine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Tissue-engineered Products
- 8.2.2. Cell Therapies
- 8.2.2.1. Autologous Therapies
- 8.2.2.2. Allogenic Therapies
- 8.2.3. Gene Therapies
- 8.2.4. Progenitor & Stem Cell Therapies
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Cardiovascular
- 8.3.2. Oncology
- 8.3.3. Dermatology
- 8.3.4. Musculoskeletal
- 8.3.5. Wound Healing
- 8.3.6. Ophthalmology
- 8.3.7. Neurology
- 8.3.8. Others
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Regenerative Medicine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Tissue-engineered Products
- 9.2.2. Cell Therapies
- 9.2.2.1. Autologous Therapies
- 9.2.2.2. Allogenic Therapies
- 9.2.3. Gene Therapies
- 9.2.4. Progenitor & Stem Cell Therapies
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Cardiovascular
- 9.3.2. Oncology
- 9.3.3. Dermatology
- 9.3.4. Musculoskeletal
- 9.3.5. Wound Healing
- 9.3.6. Ophthalmology
- 9.3.7. Neurology
- 9.3.8. Others
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Stryker Corporation
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Zimmer Biomet Holdings, Inc.
- 10.6. Medtronic Plc.
- 10.7. Athersys, Inc.
- 10.8. U.S. Stem Cell, Inc. (Bioheart, Inc.)
- 10.9. Organogenesis, Inc. (Advanced Biohealing)
- 10.10. Integra Lifesciences Holdings Corporation
- 10.11. Acelity Holdings, Inc.
- 10.12. Isto Biologics (Isto Biologics Medical Systems, Inc.)
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
